This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Why was the addition of magnesium bis glycinate reverted? This is a recently very common magnesium supplement sold in better human nutritional supplement stores. It is one of the least side effect causing mangnesium compounds with good bioavailability characteristics? Is there some format I am not following here? I will copy this comment on your talk page as well so you don't miss it. Thanks. 18.104.22.168 (talk) 05:48, 3 February 2012 (UTC)
That supplement doesn't have an article yet and we don't add things without articles to templates. That's all. Is it possible it appears under another name? -- Brangifer (talk) 06:12, 3 February 2012 (UTC)
I didn't relize that about templates. Templates are new for me. Thanks for the information. Reversion edit summary comments would have been smoother. The compound is not known under other names. It is two glycines chelated to one mangnesium. The "bis" is typed invarious ways. Sometimes as one word, and sometime separated by various characters. If I understood how to inject the article and place charts, I would do just that. Need some chemical guys to do this 22.214.171.124 (talk) 05:40, 4 February 2012 (UTC)